Effects of Short-Term Hydroxychloroquine Plus Moxifloxacin Therapy on Corrected QT Interval and Tp-e Interval in Patients With COVID-19.
Conclusions: HCQ + MOX combination therapy led to increases in QTc interval, Tp-e interval, and cTp-e interval. However, this therapy did not cause ventricular arrhythmia in the short-term observation.
PMID: 32849949 [PubMed]
Source: Clin Med Res - Category: Research Authors: Afsin A, Ecemis K, Asoglu R Tags: J Clin Med Res Source Type: research
More News: Arrhythmia | Avelox | Cancer & Oncology | Cardiology | Coronavirus | COVID-19 | Electrocardiogram | Heart | Hydroxychloroquine | Hypertension | Moxifloxacin | Pneumonia | Research | Study | Ventricular Arrhythmia